Nov 21, 2019 - Last week, Weight Watchers International rolled out myWW, offering members a customized approach to weight management. But will its new program and its rebranding effort help it recover from slimmer third-quarter revenue results?
Nov 18, 2019 - Barclays issues rating change for NVO
Nov 18, 2019 - AstraZeneca's (AZN) stock is on an upward trajectory this year. Let us take a look at the reasons for the same.
Nov 15, 2019 - Big drugmakers post better-than-expected Q3 results, leading to rise in share price of most of the companies in the industry.
Nov 14, 2019 - Eli Lilly (LLY) gets an unfavorable FDA panel vote to expand the label of its type II diabetes medicine Jardiance (2.5 mg) for type I diabetes.
Nov 13, 2019 - Top Analyst Reports for Microsoft, Novartis & Novo Nordisk
Nov 08, 2019 - Novo Nordisk (NVO) and Allergan (AGN) release Q3 results. FDA approves Sanofi's quadrivalent flu vaccine for older adults and Novartis' long-acting biosimilar version of Amgen's Neulasta.
Nov 04, 2019 - Novo Nordisk (NVO) beats earnings estimates but misses sales estimates in the third quarter of 2019.
Nov 01, 2019 - NVO earnings call for the period ending September 30, 2019.
Nov 01, 2019 - Novo Nordisk A/S (NYSE:NVO) Q3 2019 Earnings Conference Call November 01, 2019, 08:00 ET Company Participants Lars Jørgensen - President & CEO Mads Thomsen - EVP & Chief Science Officer Karste